# Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF

> **NCT02179255** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Center for Human Reproduction** · enrollment: 30 (estimated)

## Conditions studied

- Female Infertility Due to Diminished Ovarian Reserve

## Interventions

- **DRUG:** Human Growth Hormone
- **DRUG:** Follicle Stimulating Hormone

## Key facts

- **NCT ID:** NCT02179255
- **Lead sponsor:** Center for Human Reproduction
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08-01
- **Primary completion:** 2021-06
- **Final completion:** 2022-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02179255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02179255, "Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02179255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*